on BioVersys AG
BioVersys Announces 2025 Annual General Meeting of Shareholders
BioVersys AG, a company dedicated to innovative antibacterial solutions, has announced its Annual General Meeting (AGM) of Shareholders for 2025. Scheduled for June 27 at the ZIP Auditorium in Basel, the meeting's agenda includes the presentation of the 2024 Annual Report and a vote on the discharge of board members from liability.
Key agenda items include re-elections for the Board and Committee members and approval of compensation for directors and executives. Notably, Dr. Henni-Karoliina Ropponen will not seek re-election, with Dr. Ulrik Schulze proposed as a new board member.
The meeting will also address capital range amendments and an increase in conditional share capital, enhancing the company's strategic flexibility.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BioVersys AG news